Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 788 of 1,261
  1. US 8853325

    Water-soluble polymer alkanals

    Nektar Therapeutics · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  2. US 8853217

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  3. US 8853215

    Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes

    Takeda Pharmaceutical Company Limited · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  4. US 8853427

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  5. US 8853247

    Oligomer-nitroimidazole anti-infective conjugates

    Nektar Therapeutics · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  6. US 8853397

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  7. US 8853415

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  8. US 8853356

    Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

    The Regents of the University of California · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  9. US 8853277

    Nitroxide therapy for the treatment of von Hippel—Lindau disease (VHL) and renal clear cell carcinoma (RCC)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  10. US 8853252

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  11. US 8853271

    Method for inhibiting activity and/or expression of matrix metalloproteinase, inhibiting phosphorylation of mitogen-activated protein kinase, and/or promoting expression of collagen using tormentic acid

    China Medical University · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  12. US 8853254

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  13. US 8853255

    3-phenoxymethylpyrrolidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  14. US 8853244

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  15. US 8853228

    Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

    UNIVERSITY OF CONNECTICUT · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  16. US 8853205

    Heteropyrrole analogs acting on cannabinoid receptors

    UNIVERSITY OF CONNECTICUT · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  17. US 8853160

    GLP-1, exendin-4, peptide analogs and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  18. US 8852936

    Autologous lymph node transfer in combination with VEGF-C or VEGF-D growth factor therapy to treat lymphedema and to improve reconstructive surgery

    Laurantis Pharma Oy · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  19. US 8852626

    Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  20. US 8853151

    Pro-drug complexes and related methods of use

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  21. US 8853152

    Pharmaceutical compositions

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  22. US 8852940

    Embryonic stem cell specific microRNAs promote induced pluripotency

    The Regents of the University of California · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  23. US 8852151

    Swallowable drug delivery device and method of delivery

    Rani Therapeutics, LLC · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  24. US 8852598

    Puumala virus full-length M segment-based DNA vaccines

    The United States of America as represented by the Secretary of the Army · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.